Commercialization: Page
-
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Suite of Drug-Development Tools Is Available From Bruker Daltonics Bruker Daltonics has introduced the PharmaTools suite of products, which includes a feature to automatically build up libraries, i.e. for natural compounds...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Contents August 2004 Chris Henshall says all members of the brand team need a strategic understanding of the business. on the cover Life-cycle management: The ultimate client-agency relationship Life-cycle management is best achieved through a team approach that includes all stakeholders. Agencie...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
On the Cover Featured on the Cover Competitive Intelligence: Driving Better Decision Making Channeling a New Direction with Neil Levine Global Trials: Tapping New Opportunities September 2004 Volume 4 Number 9 www.pharmavo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Technology Will Revolutionize Pharma by 2010 Seven key technologies will allow pharmaceutical companies to reduce drug-development costs by 75% and cut lead times by nine years. This is the finding of a recent repo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter From the Editor Relationship building Life-cycle management takes the knowledge, savvy, and experience in all areas of pharmaceutical development, from product formulation and clinical development to navigating the regulatory review process, to building an effective marketing strategy and ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCounsel
Pharma Counsel Legal Counsel: Public Perception Minimizing Liability, Maximizing Public Perception Public perception is often more powerful than reality. If a majority believes something is true, whether it is or not is beside the point. Pharmaceutical companies are facing a difficult reality: ho...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Trials Around the World
Trials Around the World By Denise Myshko Many pharmaceutical companies and CROs are tapping Eastern Europe, Asia, Latin America, and other areas to meet their clinical-trial needs. While there are challenges associated with conducting research in nontraditional geographic regions – such as nascen...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Beyond Passwords
Beyond Passwords By Denise Myshko Biometrics – technologies that allow people to be identified by fingerprints or other biological markers, such as iris scans – is receiving increased attention by companies in many industries concerned about security, not only for their premises but also for thei...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Christopher Clement Savient Pharmaceuticals Names CEO Savient Pharmaceuticals has named Christopher Clement CEO, in addition to his role as president. Savient, East Brunswick, N.J., is engaged in developing, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Improving Advocacy Relations
Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Life-Cycle Management: The Ultimate Client-Agency Relationship
Life-cycle Management The Ultimate Client-Agency Relationship By Elisabeth Pena With $80 billion of products facing patent expiration by 2008, fewer drugs in the pipeline, greater generic competition, and decreasing revenue and growth rates, the pharmaceutical industry is facing some of its bigge...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Kareem Saad -- Big Blue's Genomics Ace
By Kim Ribbink Big Blue’s Genomics Ace Young and talented, Kareem Saad, IBM’s worldwide business segment executive for clinical genomics, is overseeing the company’s initiative to take clinical genomics from concept to market. With youthful enthusiasm, innate technical and scientific intelligence...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Joy A. Amundson Bruce McGillivray Jim Utts Baxter Appoints and Promotes Executives Baxter International has named Joy A. Amundson corporate VP and president of its bioscience business. Baxter, Deerfield, Ill....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies CommonHealth Launches Interactive Agency Qi Interactive addresses clients’ digital and online needs. CommonHealth has launched Qi Interactive, a full-service digital agency. The new unit focuses on interactive and Web-based solut...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends Affecting the Healthcare Industry Public Awareness of Clinical Trials Grows Awareness of clinical trials among the general public has grown over the last three years, while physicians struggle to find the time, personnel, and resources to participa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Neil Levine: In Good Company
In Good Company By Kim Ribbink Neil Levine has spent most of his career at one company, Pfizer, not only because of the myriad opportunities he has been given at the world’s largest pharmaceutical company, but, he says, because of the people he works with, the company’s values, And its commitment...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter From The Editor According to Cutting Edge Information’s study, 88% of surveyed companies’ market-research teams were involved in collecting and analyzing competitive intelligence. Companies across multiple industries are recognizing the overlap between market research and competitive intel...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies PhRMA Adopts Clinical-Trial Principles Voluntary principles describe the relationship of PhRMA companies with others involved in clinical research and establish the rules to protect the safety of research participants. The Pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a Case for Rebranding The Rebranding of a Brander Healthcare advertising agencies, among their many strategic and creative services, excel at branding or rebranding pharmaceutical products, devices, diagnostics, and corporate identities for their clients. Harder to do is to apply those sam...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends affecting the healthcare industry The Biodefense Market to Grow Biodefense research is one of the fastest growing markets for suppliers of life-sciences products and instrumentation. When the budget allocated to the Department of Health and Human S...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Patient Registries: Observations of the Real World
Patient registries Observations of the Real World By Denise Myshko There is no such thing as a standard registry. We have to strike a balance: do we ask a lot of questions or just a few? We also need to consider the work load for the investigators. DR. herve Caspard Through patient registries, ph...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
August 2004 PharmaVOICE The forum for the industry executive Working Toward Common Goals agency-Client relationships a journey of discovery with Frank Baldino Deriving Value from patient registries www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008
Previous
